June 19, 2006 Issue | Chemical & Engineering News
 
 

What Is Tinsel Made Of? Speaking of Chemistry Ep. 12

How is the shiny tinsel that decorates many Christmas trees made? Find out all about tinsel's chemistry history in this very special holiday episode of Speaking of Chemistry.

 
Copyright © 2006 American Chemical Society
 

June 19, 2006 Issue

Volume 84, Issue 25
8425introimg1
June 19, 2006 Issue, Vol. 84 | Iss. 25
C&EN examines how the pharmaceutical industry, now on the defensive, is trying to win back the public's confidence and enhance productivity
By A. Maureen Rouhi
(pp. 24-28)
Features
Science & Technology
Asymmetric reaction constructs three new C-C bonds and four stereocenters (p.13)
Business
Fundamental changes erupt across the industry as companies strive to improve drug efficacy and safety and R&D efficiency in the face of negative public opinion (pp. 30-55)
Back Issues
 

News of the Week

Triple Cascade

Asymmetric reaction constructs three new C-C bonds and four stereocenters
(p.13)

Georgia Gulf Will Buy Royal Group

Deal will create a large, back-integrated vinyl products supplier
(p.14)

Greener Cleaners

EPA initiative urging phaseout of NPE surfactants receives mixed reviews
(p.14)

Aging Cells Get New Lease On Life

Small molecule is found to extend lifetime of mammalian cells
(p.15)

Schering Shares

Merck's threat to derail Bayer's acquisition of Schering is resolved
(p.15)

Herzenberg Nabs Kyoto Prize

Award honors the developer of the fluorescence-activated cell sorter
(p.16)
 

Departments

8425pharma1_paulacxd1

Business

Researchers Are Admonished To Stay Focused
(pp. 42-43)
Many Doubt The $800 Million Pharmaceutical Price Tag
(p.50)
Fundamental changes erupt across the industry as companies strive to improve drug efficacy and safety and R&D efficiency in the face of negative public opinion
(pp. 30-55)
C&EN examines how the pharmaceutical industry, now on the defensive, is trying to win back the public's confidence and enhance productivity
(pp. 24-28)
8425pharma3_box1cxd

Government & Policy

For Most Retirees, Medicare Program Fails To Lower Costs
(pp. 84-85)
Citing Application Backlog, Makers Of Generic Drugs Seek To Boost FDA Funding
(p.92)
Strong action on drug safety and pricing is more likely to come from states than from Congress or FDA
(pp. 80-99)
FDA Process Guidelines Encourage Efficient Plant Controls
(p.66)